Posted On: 11/10/2014 5:43:40 PM
Post# of 30065
I'm asking myself how are they going to pay for an Eltop Phase 2b trial, and a Phase 1 MANF trial if Jason's $1M 2015 revenue forecast is accurate and there are no classic partnerships?
Without lots of cash, they can't pay for those activities UNLESS they uplist to gain access to institutional investors. I know GC said they would only uplist from a position of strength. But his and my interpretation of what that means could be worlds apart.
$0.08 doesn't feel strong to me!
Without lots of cash, they can't pay for those activities UNLESS they uplist to gain access to institutional investors. I know GC said they would only uplist from a position of strength. But his and my interpretation of what that means could be worlds apart.
$0.08 doesn't feel strong to me!
(0)
(0)
